What Every Investor Must Know About EQNR Stock

It's been a great evening session for Equinor ASA investors, who saw their shares rise 2.8% to a price of $31.71 per share. At these higher prices, is the company still fairly valued? If you are thinking about investing, make sure to check the company's fundamentals before making a decision.

Equinor ASA Shares Are Inexpensive:

Equinor ASA, an energy company, engages in the exploration, production, transportation, refining, and marketing of petroleum and other forms of energy in Norway and internationally. The company belongs to the Energy sector, which has an average price to earnings (P/E) ratio of 8.53 and an average price to book (P/B) ratio of 1.78. In contrast, Equinor ASA has a trailing 12 month P/E ratio of 5.7 and a P/B ratio of 1.93.

Equinor ASA has moved -14.9% over the last year compared to 23.6% for the S&P 500 — a difference of -38.5%. Equinor ASA has a 52 week high of $37.58 and a 52 week low of $25.23.

The Business Runs With Low Leverage Levels:

2018 2019 2020 2021 2022 2023
Revenue (MM) $79,593 $79,593 $64,357 $90,924 $150,806 $150,806
Revenue Growth n/a 0.0% -19.14% 41.28% 65.86% 0.0%
Operating Margins 25% 25% 14% 37% 52% 52%
Net Margins 9% 9% 3% 9% 19% 19%
Net Income (MM) $7,538 $7,538 $2,174 $8,576 $28,746 $28,746
Net Interest Expense (MM) -$351 -$7 -$7 -$836 -$207 -$207
Depreciation & Amort. (MM) $9,249 $13,204 $15,235 $15,235 $11,719 $8,878
Free Cash Flow (MM) $19,694 $19,694 $13,749 $28,816 $35,136 $35,136
Current Ratio 1.37 1.33 1.58 1.59 1.77 1.77
Total Debt (MM) $67,630 $75,193 $86,160 $97,238 $97,238 $93,719
Net Debt / EBITDA 2.04 2.03 3.24 1.7 0.9 0.89

Equinor ASA has growing revenues and no capital expenditures and low leverage. Additionally, the company's financial statements display decent operating margins with a positive growth rate and irregular cash flows. Furthermore, Equinor ASA has positive expected EPS Growth.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS